Related Experiment Video
Updated: May 20, 2025

03:37
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
616
CLMT: graph contrastive learning model for microbe-drug associations prediction with transformer
Liqi Xiao1, Junlong Wu1, Liu Fan1
1College of Computer Science and Technology, Hengyang Normal University, Hengyang, China.
Frontiers in Genetics
|March 27, 2025
Summary
This study introduces CLMT, a novel model for predicting microbe-drug associations. CLMT utilizes a Graph Transformer and contrastive learning to improve accuracy, especially with sparse data.
Area of Science:
- Computational Biology
- Bioinformatics
- Drug Discovery
Background:
- Accurate microbe-drug association prediction is crucial for drug development and disease diagnosis.
- Existing methods face challenges in modeling complex nonlinear relationships and long-range dependencies.
- Distinguishing subtle similarities between microbes and drugs remains a significant hurdle.
Purpose of the Study:
- To develop an advanced model for microbe-drug association prediction.
- To address limitations of current methods in capturing complex interactions and sparse data.
- To enhance the accuracy and generalizability of microbe-drug association predictions.
Main Methods:
- CLMT model integrating Graph Transformer network with an attention mechanism.
- Application of graph contrastive learning with node perturbation and edge dropout for data augmentation.
- Optimization using a contrastive loss to learn robust and generalizable embeddings.
Main Results:
- CLMT significantly outperforms existing methods in microbe-drug association prediction.
- Demonstrated state-of-the-art performance on MDAD, aBiofilm, and Drug Virus datasets.
- Achieved accuracy improvements of 4.3%, 3.5%, and 2.8% over the previous best model, respectively.
Conclusions:
- CLMT effectively mitigates data sparsity and captures nonlinear microbe-drug interactions.
- The model's architecture enhances the ability to model high-order dependencies and long-range associations.
- CLMT shows significant promise for real-world biomedical applications in drug development and diagnostics.
Related Concept Videos
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Combined Effects of Drugs: Antagonism
8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K
Drug Concentration Versus Time Correlation
561
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
561

